University Hospitals Birmingham NHS Foundation Trust

Search results for ""

Status Drug name NICE TAs Comments
Status: Amber Aviptadil 25mcg / Phentolamine 2mg intracavernosal injection (Invicorp®)

Approved on formulary December 2017. Specialist initiation. Third line after oral PDE-5 inhibitors failed and patient not responding to or intolerant of alprostadil. To be reviewed within 12 months to assess alprostadil supply issues and patent expiry
Status: Red Axicabtagene ciloleucel  (Yescarta®)
Status: Red Axitinib

National CDF list
Status: Amber Aymes® creme (semi-solid)
Status: Red Azacitidine (Vidaza®)

For hospital use only
Status: Amber Azarga eye drops

Specialist ophthalmologist recommendation
Status: Amber Azathioprine

To be administered in conjunction with prednisolone (plain tablets). Supported by ESCA.
Status: Red Azathioprine injection

For hospital use only
Status: Red Azathioprine suspension
Status: Amber Azathioprine tablets

ESCA
Building healthier lives
Back to top